Convergys (CVG) Cash Flow Statement

Click line-items for a historical chart and %

Net income	125.5M
Income from discontinued operations	10M
Income from continuing operations	115.5M
Depreciation and amortization	114.2M
Gain on sale of business, net of deferred tax expense of $2.7
Deferred income tax expense	-6M
Earnings from Cellular Partnerships, net
Distributions from Cellular Partnerships
Stock compensation expense	12.8M
Change in receivables	23.1M
Change in other current assets	-9.3M
Change in deferred charges, net	600K
Change in other assets and liabilities	-1.2M
Change in payables and other current liabilities	-12.9M
Net cash provided by operating activities of continuing operations
Net cash used in operating activities of discontinued operations
Net cash provided by operating activities	236.8M
Capital expenditures	-63.6M
Proceeds from disposition of business
Acquisitions, net of cash acquired	129.9M
Net cash used in investing activities of continuing operations
Net cash provided by investing activities of discontinued operations
Net cash (used in) provided by investing activities	-194.3M
Repayments of credit facilities and other debt, net
Purchase of treasury shares	-54.3M
Proceeds from exercise of stock options	600K
Other
Net cash used in financing activities	-118.1M
Net decrease in cash and cash equivalents	-75.6M
Cash and cash equivalents at beginning of period	204.7M
Cash and cash equivalents at end of period	129.1M

Entities mentioned with CVG

View All Entities